Zotefoams (LON:ZTF) Given New GBX 570 Price Target at Canaccord Genuity

Zotefoams (LON:ZTF) had its target price increased by Canaccord Genuity from GBX 550 ($7.72) to GBX 570 ($8.00) in a report published on Wednesday, March 14th. Canaccord Genuity currently has a buy rating on the stock.

Shares of LON ZTF traded up GBX 20 ($0.28) during midday trading on Wednesday, reaching GBX 550 ($7.72). 13,401 shares of the stock were exchanged, compared to its average volume of 61,457. Zotefoams has a twelve month low of GBX 280 ($3.93) and a twelve month high of GBX 532 ($7.47).

How to Become a New Pot Stock Millionaire

The company also recently disclosed a dividend, which will be paid on Thursday, May 24th. Stockholders of record on Thursday, April 19th will be given a dividend of GBX 4.02 ($0.06) per share. This is a boost from Zotefoams’s previous dividend of $1.91. This represents a dividend yield of 0.76%. The ex-dividend date of this dividend is Thursday, April 19th.

COPYRIGHT VIOLATION WARNING: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/08/canaccord-genuity-boosts-zotefoams-ztf-price-target-to-gbx-570.html.

About Zotefoams

Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polymer foam in the United Kingdom and Eire, Continental Europe, North America, and internationally. The company operates through Polyolefins, High-Performance Products (HPP), and MuCell Extrusion LLC (MEL) segments. It offers AZOTE family of polyolefin foams under the Plastazote, Evazote, and Supazote brands; ZOTEK range of high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK F, ZOTEK N, and ZOTEK PEBA brand names.

Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply